Treating ectopic pregnancy with the combination of mifepristone and methotrexate: a phase II nonrandomized study
- PMID: 9757964
- DOI: 10.1016/s0002-9378(98)70057-2
Treating ectopic pregnancy with the combination of mifepristone and methotrexate: a phase II nonrandomized study
Abstract
Objective: Our goal was to compare the use of a combination of methotrexate and mifepristone with methotrexate alone in the medical management of ectopic pregnancy.
Study design: This was a preliminary nonrandomized phase II study. All patients with progressing ectopic pregnancy meeting criteria for medical management were included. Treatment consisted of 50 mg/m2 of methotrexate injected intramuscularly and 600 mg of mifepristone, administered orally, compared with a previous group who received only 50 mg/m2 of methotrexate injected intramuscularly.
Results: Of the 30 patients treated with the combination, there was only 1 failure, whereas medical treatment had failed for 11 of 42 patients treated with methotrexate alone.
Conclusions: The combination of mifepristone and methotrexate decreased the risk of failure in medical treatment of ectopic pregnancy.
Comment in
-
Mifepristone and methotrexate: the combination for medical treatment of ectopic pregnancy.Am J Obstet Gynecol. 1999 Jun;180(6 Pt 1):1599-600. doi: 10.1016/s0002-9378(99)70067-0. Am J Obstet Gynecol. 1999. PMID: 10368554 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical